Clinical trial Recruiting at 3 sites Observational Ages 3 and up

See if SalivIQ Strep A detects strep throat in kids and adults

Official title: A Multicenter Evaluation of SalivIQ™ Strep A for Detecting Group A Streptococcus From Saliva and Throat Swabs in Patients With Acute Pharyngitis

Run by SalivIQ Diagnostics, Inc. · NCT07891728 · Data updated 2026-11-12

This study tests whether the SalivIQ Strep A test can correctly identify Group A Streptococcus in people with suspected strep throat using saliva and throat swabs.

More Streptococcal Pharyngitis trials

Quick facts

Study typeObservational
Ages3 Years and up
SexAll
Enrollment668 (estimated)
SponsorSalivIQ Diagnostics, Inc.
Industry-sponsored
Locations3 sites (Baton Rouge, Louisiana and 2 other locations)
StatusRecruiting
StartedOctober 9, 2026
Main results expectedJanuary 31, 2027
Study endsMarch 15, 2027
Registry record updatedNovember 2, 2026
Trial IDNCT07891728 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3 years and older or adults with signs of pharyngitis who have not used antibiotics in the past 7 days.

Probably not a fit

Patients with non-GAS pharyngitis or those unlikely to benefit from rapid testing may not receive diagnostic benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter observational study evaluates the diagnostic performance of the SalivIQ Strep A test for detecting Group A Streptococcus in saliva and throat swabs. It includes adults and children aged 3 years and older who show signs of acute pharyngitis. Participants undergo standard care testing and additional SalivIQ testing, with results compared to reference laboratory tests. The study is conducted at CLIA-waived sites with blinded assessment and aims to enroll about 668 participants to achieve at least 100 GAS-positive cases. The order of specimen collection is standardized to minimize bias.

Why it matters

Potential benefit: If successful, the SalivIQ Strep A test could provide a rapid, noninvasive method to help diagnose strep throat.

How similar studies have gone: Prior studies in similar diagnostic settings have shown promise for saliva- and swab-based tests, but this exact approach with SalivIQ Strep A is being evaluated anew.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (age 18 years or older) or minor patients (3-17 years) with an accompanying adult
* Patient exhibits signs and symptoms of pharyngitis, such as sudden onset of sore throat, pain with swallowing, and fever
* Willing and able to provide consent and assent to participate in the study

Exclusion Criteria:

* Prior antibiotic use within the past 7 days

Where it's running

  • Patient Plus Urgent Care
    Baton Rouge, Louisiana, United States
    Recruiting
  • American Family Care
    North Andover, Massachusetts, United States
    Recruiting
  • PM Pediatrics
    Dallas, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • VAX-A1: a first-in-human test for safety and immune response in healthy adults

    This phase 1 trial tests a new vaccine called VAX-A1 in healthy adults 18-40 to see if it is safe, tolerable, and can provoke an immune response.

    Recruiting Phase 1 Vaxcyte, Inc. · Adelaide, South Australia · NCT07616934

  • Understanding Group A Streptococcus in Children

    This study is trying to understand the differences in Group A strep bacteria between kids who are sick and those who carry the bacteria without symptoms, to help improve treatment options.

    Recruiting University of Wisconsin, Madison · Madison, Wisconsin · NCT01558804

  • Evaluating patterns in neurodevelopmental disorders

    This study is trying to find common signs and causes of neurodevelopmental disorders like Autism and Down Syndrome to help with earlier diagnosis and better outcomes for those affected.

    Recruiting Rossignol Medical Center · Phoenix, Arizona · NCT06213090

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.